Evidence map›Paper›PMID 24695092›Full record

ArticleBiomaterials2014

The effect of scaffold macroporosity on angiogenesis and cell survival in tissue-engineered smooth muscle.

Christopher M Walthers, Alireza K Nazemi, Shilpy L Patel, Benjamin M Wu, James C Y Dunn

Abstract read
In one paragraph

Article in Biomaterials, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 94 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Frontiers in bioengineering and biotechnology · 2023
    Article
  14. Article
  15. Article
  16. Effect of Angiogenesis in Bone Tissue Engineering.Annals of biomedical engineering · 2022
    Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Christopher M WalthersDepartment of Bioengineering, University of California, Los Angeles, CA 90095, USA.
Alireza K NazemiDepartment of Bioengineering, University of California, Los Angeles, CA 90095, USA.
Shilpy L PatelDepartment of Bioengineering, University of California, Los Angeles, CA 90095, USA.
Benjamin M WuDepartment of Bioengineering, University of California, Los Angeles, CA 90095, USA; Department of Advanced Prosthodontics, Biomaterials, and Hospital Dentistry, University of California, Los Angeles, CA, USA.
James C Y DunnDepartment of Bioengineering, University of California, Los Angeles, CA 90095, USA; Department of Surgery, University of California, Los Angeles, CA, USA. Electronic address: jdunn@mednet.ucla.edu.
University of California, Los Angeles · US

Funding

Intestinal Tissue EngineeringR01DK083319 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DUNN, JAMES C · 2010 to 2012
$998k
NIDDK NIH HHS R01 DK083119NIDDK NIH HHS R01 DK083319
6 · The paper itself

Abstract

Angiogenesis and survival of cells within thick scaffolds is a major concern in tissue engineering. The purpose of this study is to increase the survival of intestinal smooth muscle cells (SMCs) in implanted tissue-engineered constructs. We incorporated 250-μm pores in multi-layered, electrospun scaffolds with a macroporosity ranging from 15% to 25% to facilitate angiogenesis. The survival of green fluorescent protein (GFP)-expressing SMCs was evaluated after 2 weeks of implantation. Whereas host cellular infiltration was similar in scaffolds with different macroporosities, blood vessel development increased with increasing macroporosity. Scaffolds with 25% macropores had the most GFP-expressing SMCs, which correlated with the highest degree of angiogenesis over 1 mm away from the outermost layer. The 25% macroporous group exceeded a critical threshold of macropore connectivity, accelerating angiogenesis and improving implanted cell survival in a tissue-engineered smooth muscle construct.

Indexed as

AnimalsCells, CulturedCell SurvivalImmunohistochemistryMyocytes, Smooth MuscleNeovascularization, PhysiologicPolyestersPorosityRatsTissue EngineeringTissue ScaffoldspolycaprolactonePolyestersAngiogenesisPolycaprolactonePorositySmooth muscle constructsTissue engineering

Identifiers

PMID24695092
PMCPMC4018739
OpenAlexW2045616244

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.